article

1. Salt and Atopic Dermatitis-Reply..  JAMA dermatology.  2024
2. The importance of pathway programs in increasing diversity in dermatology: Efforts made by the American Academy of Dermatology..  Journal of the American Academy of Dermatology.  2024
3. Inflammation and aging-related disease: A transdisciplinary inflammaging framework..  GeroScience.  2024
4. Atopic dermatitis and tobacco smoke exposure during childhood and adolescence..  The journal of allergy and clinical immunology. Global.  4:-. 2024
5. Air Pollution and Inflammatory Skin Disease-Can Clinicians Make Recommendations to Reduce Risk?.  JAMA network open.  7:-. 2024
6. Antihypertensive Medications and Eczematous Dermatitis in Older Adults..  JAMA dermatology.  160:710-716. 2024
7. Sodium Intake and Atopic Dermatitis..  JAMA dermatology.  160:725-731. 2024
8. Utility of transepidermal water loss-stratum corneum hydration ratio in atopic dermatitis..  Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI).  30:-. 2024
9. Atopic dermatitis, cognitive function and psychiatric comorbidities across early childhood and adolescence in a population-based UK birth cohort..  The British journal of dermatology.  190:501-509. 2024
10. Estimating geographic variation of infection fatality ratios during epidemics..  Infectious Disease Modelling.  9:634-643. 2024
11. Impact of climate change on atopic dermatitis: A review by the International Eczema Council..  Allergy.  79:1455-1469. 2024
12. Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors..  American journal of clinical dermatology.  25:179-193. 2024
13. Atopic dermatitis and risk for headache disorders and migraines: a population-based cohort study in children and adults from the UK..  The British journal of dermatology.  190:120-123. 2023
14. Mental Health Interventions for Atopic Dermatitis: Knowledge Gaps, Pilot Programs, and Future Directions..  Clinical and experimental dermatology.  49:9-17. 2023
15. Role of locus of control in emotional and behavioural outcomes among children with atopic dermatitis..  Journal of the European Academy of Dermatology and Venereology : JEADV.  38:e500-e503. 2023
16. Atopic Dermatitis and Cardiovascular Risk in Pediatric Patients: A Systematic Review and Meta-Analysis..  The Journal of investigative dermatology.  144:1038-1047.e16. 2023
17. Incident Asthma, Asthma Exacerbations, and Asthma-Related Hospitalizations in Patients With Atopic Dermatitis..  The journal of allergy and clinical immunology. In practice.  12:421-430.e1. 2023
18. Fasting blood glucose and insulin are not associated with atopic dermatitis in a pediatric population: A longitudinal cohort study from the Avon Longitudinal Study of Parents and Children..  JAAD international.  12-14. 2023
19. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation..  Nature communications.  14:-. 2023
20. Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis..  JAMA dermatology.  159:1085-1092. 2023
21. Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis..  JAMA dermatology.  159:1119-1123. 2023
22. Neuropsychiatric disorders in adults with atopic dermatitis: A population-based cohort study..  Journal of the European Academy of Dermatology and Venereology : JEADV.  38:543-548. 2023
23. Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis..  The journal of allergy and clinical immunology. In practice.  11:3123-3132.e3. 2023
24. Malignancy risk in patients with atopic dermatitis: a population-based cohort study..  The British journal of dermatology.  189:53-61. 2023
25. Sodium in the Skin: A summary of the physiology and scoping review of disease associations..  Clinical and experimental dermatology.  48:733-743. 2023
26. Atopic dermatitis across the life course..  The British journal of dermatology.  188:709-717. 2023
27. Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials..  American journal of clinical dermatology.  24:-. 2023
28. Prevalence and Burden of Atopic Dermatitis Involving the Head, Neck, Face, and Hand: A Cross Sectional Study from the TARGET-DERM AD Cohort..  Journal of the American Academy of Dermatology.  89:519-528. 2023
29. Distribution of Early Career Research Funding by Specialty from the National Institute of Arthritis and Musculoskeletal and Skin Diseases..  The Journal of investigative dermatology.  143:688-690.e2. 2023
30. Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials..  American journal of clinical dermatology.  24:469-483. 2023
31. Air Pollution and Atopic Dermatitis, from Molecular Mechanisms to Population-Level Evidence: A Review..  International journal of environmental research and public health.  20. 2023
32. The association between atopic eczema and lymphopenia: Results from a UK cohort study with replication in US survey data..  Journal of the European Academy of Dermatology and Venereology : JEADV.  37:1190-1198. 2023
33. Association of fracture incidence in children with the development of food allergy: A Korean nationwide birth cohort study..  Allergy.  78:858-862. 2023
34. Skin Barrier Function and Cognition Among Older Adults..  The Journal of investigative dermatology.  143:1085-1087. 2023
35. Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort..  Journal of the American Academy of Dermatology.  89:345-347. 2022
36. National trends in the prevalence of allergic diseases among Korean adolescents before and during COVID-19, 2009-2021: A serial analysis of the national representative study..  Allergy.  78:1665-1670. 2022
37. Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients..  JAMA dermatology.  158:1404-1408. 2022
38. Fracture incidence in children after developing atopic dermatitis: A Korean nationwide birth cohort study..  Allergy.  78:871-875. 2022
39. The impact of dermatitis on health-related quality of life: Data from the National Health and Nutrition Examination Survey..  Journal of the European Academy of Dermatology and Venereology : JEADV.  37:e175-e179. 2022
40. Qualitative analysis of the impact of atopic dermatitis on caregivers and the quantitative impact of atopic dermatitis on caregivers across multiple life domains..  The British journal of dermatology.  187:1038-1041. 2022
41. The quantitative impact of atopic dermatitis on caregivers across multiple life domains..  The British journal of dermatology.  187:1041-1043. 2022
42. Atopic dermatitis and risk of major neuropsychiatric disorders in children: A population-based cohort study..  Journal of the European Academy of Dermatology and Venereology : JEADV.  37:114-122. 2022
43. Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID-19 pandemic: A cross-sectional study..  Pediatric dermatology.  39:718-726. 2022
44. Sleep-Disordered Breathing and Sleep Quality in a Longitudinal Pediatric Cohort..  Clinical pediatrics.  61:-. 2022
45. Adult atopic eczema and the risk of dementia: A population-based cohort study..  Journal of the American Academy of Dermatology.  87:314-322. 2022
46. Association Between Homelessness and Group A Streptococcus Skin and Soft Tissue Infections Among Hospitalized Dermatology Consult Patients..  JAMA dermatology.  158:321-323. 2022
47. The epidemiology of atopic dermatitis in older adults: A population-based study in the United Kingdom..  PloS one.  16:-. 2021
48. Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood: A Longitudinal Cohort Study..  JAMA dermatology.  157:1200-1208. 2021
49. Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts..  JAMA dermatology.  157:1191-1199. 2021
50. Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: A systematic review..  Journal of the American Academy of Dermatology.  86:399-405. 2021
51. Phenotypic overlap between atopic dermatitis and autism..  BMC neuroscience.  22:-. 2021
52. Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch..  JAMA dermatology.  157:658-666. 2021
53. Atopic Dermatitis and Academic Achievement-More to Learn..  JAMA dermatology.  2021
54. Atopic eczema in adulthood and mortality: UK population-based cohort study, 1998-2016..  The Journal of allergy and clinical immunology.  147:1753-1763. 2021
55. International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale..  BMJ open.  10:-. 2020
56. Prenatal and Childhood Tobacco Smoke Exposure Are Associated With Sleep-Disordered Breathing Throughout Early Childhood..  Academic pediatrics.  21:654-662. 2020
57. Association Between Atopic Eczema and Cancer in England and Denmark..  JAMA dermatology.  156:1086-1097. 2020
58. The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017..  JAMA dermatology.  156:874-881. 2020
59. Influence of Contraception Class on Incidence and Severity of Acne Vulgaris..  Obstetrics and gynecology.  135:1306-1312. 2020
60. Atopic eczema and fracture risk in adults: A population-based cohort study..  The Journal of allergy and clinical immunology.  145:563-571.e8. 2019
61. By protecting against cutaneous inflammation, epidermal pigmentation provided an additional advantage for ancestral humans..  Evolutionary applications.  12:1960-1970. 2019
62. Atopic Eczema in Adulthood and Risk of Depression and Anxiety: A Population-Based Cohort Study..  The journal of allergy and clinical immunology. In practice.  8:248-257.e16. 2019
63. Genetic ancestry does not explain increased atopic dermatitis susceptibility or worse disease control among African American subjects in 2 large US cohorts..  The Journal of allergy and clinical immunology.  145:192-198.e11. 2019
64. Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife..  The Journal of allergy and clinical immunology.  144:710-719. 2019
65. Association of Atopic Dermatitis With Sleep Quality in Children..  JAMA pediatrics.  173:-. 2019
66. Assessment of Sleep Disturbances and Exhaustion in Mothers of Children With Atopic Dermatitis..  JAMA dermatology.  155:556-563. 2019
67. Atopic eczema and major cardiovascular outcomes: A systematic review and meta-analysis of population-based studies..  The Journal of allergy and clinical immunology.  143:1821-1829. 2018
68. Prevalence of Atopic Eczema Among Patients Seen in Primary Care: Data From The Health Improvement Network..  Annals of internal medicine.  170:354-356. 2018
69. Classifying atopic dermatitis: protocol for a systematic review of subtypes (phenotypes) and associated characteristics..  BMJ open.  8:-. 2018
70. Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study..  BMJ (Clinical research ed.).  -. 2018
71. How data can deliver for dermatology..  Journal of the American Academy of Dermatology.  79:400-402. 2018
72. Incidence and sociodemographic characteristics of eczema diagnosis in children: A cohort study..  The Journal of allergy and clinical immunology.  141:1927-1929.e8. 2018
73. Association between childhood allergic diseases, educational attainment and occupational status in later life: systematic review protocol..  BMJ open.  7:-. 2017
74. Association between eczema and major cardiovascular outcomes in population-based studies: a systematic review protocol..  BMJ open.  7:-. 2017
75. Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study..  The Journal of allergy and clinical immunology.  141:778-780.e6. 2017
76. Conclusions about atopic dermatitis persistence might be premature..  Journal of the American Academy of Dermatology.  76:e177-e178. 2017
77. The Long-Term Course of Atopic Dermatitis..  Dermatologic clinics.  35:291-297. 2017
78. Development and Validation of an Algorithm to Accurately Identify Atopic Eczema Patients in Primary Care Electronic Health Records from the UK..  The Journal of investigative dermatology.  137:1655-1662. 2017
79. Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis-A Cohort Study..  The Journal of investigative dermatology.  137:1375-1377. 2017
80. Comparisons of patients’ satisfaction should take expectations into account.  British Journal of Dermatology.  2017
81. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review..  Journal of the American Academy of Dermatology.  75:1038-1044. 2016
82. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).  British Journal of Dermatology.  2016
83. Association between leukemia and topical use of pimecrolimus: In reply.  JAMA Dermatology.  2015
84. Association between malignancy and topical use of pimecrolimus.  JAMA Dermatology.  2015
85. Atopic dermatitis disease control and age: A cohort study.  Journal of Allergy and Clinical Immunology.  2015
86. Databases for Clinical Research.  Journal of Investigative Dermatology.  2015
87. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013.  The Lancet.  2015
88. Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.  British Journal of Dermatology.  2015
89. Alcohol-induced vasculitis: Case report and commentary.  Journal of the American Academy of Dermatology.  2014
90. Antibiotic sensitivity and resistance patterns in pediatric staphylococcal scalded skin syndrome.  Pediatric Dermatology.  2014
91. Mucinous nevus: Report of a case and review of the literature.  JAMA Dermatology.  2014
92. Persistence of mild to moderate atopic dermatitis.  JAMA Dermatology.  2014
93. The diagnostic challenge of vulvar squamous cell carcinoma: Clinical manifestations and unusual human papillomavirus types.  Journal of the American Academy of Dermatology.  2014
94. Do children really outgrow their eczema, or is there more than one eczema?.  Journal of Allergy and Clinical Immunology.  2013
95. Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis.  Journal of the American Academy of Dermatology.  2013
96. A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men.  Archives of Dermatology.  2012
97. Association of systemic psoriasis therapies and incidence of myocardial infarction: Reply from authors.  British Journal of Dermatology.  2012
98. Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients.  Journal of the American Academy of Dermatology.  2012
99. Dermatologist preferences for treatments to compare in future randomized controlled comparative effectiveness trials for moderate to severe psoriasis.  Archives of Dermatology.  2012
100. Dermatologist response rates to a mailed questionnaire: A randomized trial of monetary incentives.  Journal of the American Academy of Dermatology.  2012
101. The role of systematic reviews and meta-analysis in dermatology.  Journal of Investigative Dermatology.  2012
102. The role of systematic reviews and meta-analysis in dermatology..  The Journal of investigative dermatology.  2012
103. Reliability and validity of a photographic method for measuring facial hair density in men.  Archives of Dermatology.  2011
104. The effect of systemic psoriasis therapies on the incidence of myocardial infarction: A cohort study.  British Journal of Dermatology.  2011
105. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials.  Journal of the American Academy of Dermatology.  2011
106. Validity of the Health Improvement Network (THIN) for the study of psoriasis.  British Journal of Dermatology.  2011
107. Adherence to treatment: Still the forgotten variable - Reply.  Archives of Dermatology.  2010
108. Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the U.K..  British Journal of Dermatology.  2010
109. Diet and weight loss as a treatment for psoriasis.  Archives of Dermatology.  2010
110. Briakinumab.  Expert Opinion on Biological Therapy.  2009
111. Oral contraceptives for acne and sexual practices.  Journal of the American Academy of Dermatology.  2009
112. Abuse during pregnancy in Mexico City.  International Journal of Gynecology and Obstetrics.  2007
113. Barriers to contraceptive use in product labeling and practice guidelines.  American Journal of Public Health.  2006
114. Pharmacy provision of medical abortifacients in a Latin American city.  Contraception.  2006
115. Risk of pregnancy and external validity in clinical trials of emergency contraception.  Journal of Family Planning and Reproductive Health Care.  2006
116. As often as needed: Appropriate use of emergency contraceptive pills.  Contraception.  2004
117. Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries.  Contraception.  2004
118. Differences between emergency contraception users in the United States and the United Kingdom..  Journal of the American Medical Women's Association (1972).  2002